source
- Coming SoonNext installments of the biopharma pay series coming soonEndpoints · 1mo ago↗ source
- STAT+: Novo underwhelmed by drug it once fought Pfizer forRevolution and Tango yield promising cancer results, Incyte buys bleeding disorder drug, and more biotech newsSTAT · 1mo ago↗ source
- Biopharma's top-paid CEOs of 2025: 25 making $25M+For the first time in four years, Endpoints News is raising the bar for what it means to be a top-paid CEO. The previous floor of $20 million is no longer rich enough. The biopharma ...Endpoints · 1mo ago↗ source